New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
For full access to this article login to GEN Select now.
Variability Still an Issue for Culture Media
Chemically Defined Media Achieve Consistency, not Universality—Not without Supplements
- Cell culture preferences have slowly shifted from serum-based to hydrolysate-supplemented to chemically defined. Dominant drivers for this trend have been a desire for consistency in product titer and quality, and a greater appreciation for process understanding. “The unexpected problem,” says Jon Wannlund, Ph.D., director of R&D for advanced ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.